Avricore Health (AVCRF) Cash from Investing Activities (2014 - 2025)

Avricore Health has disclosed Cash from Investing Activities across 8 years of filings, most recently posting -$77501.4 for Q3 2025.

• In Q3 2025, Cash from Investing Activities rose 45.21% year-over-year to -$77501.4; the TTM figure through Sep 2025 stood at -$340023.1 (up 39.31% YoY), while the FY2025 annual figure was -$81851.3, up 45.43% from the prior year.
• Cash from Investing Activities declined to -$77501.4 in Q3 2025, from -$63653.6 in the prior quarter.
• Over the last five years, Cash from Investing Activities for AVCRF reached as high as -$917.37 in Q1 2022 and fell as low as -$467863.2 in Q3 2022.
• The 5-year median for Cash from Investing Activities is -$84329.7 (2024), against an average of -$127636.0.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities surged 72.99% — and 2023, when it plunged 18285.52%.
• A 5-year view of Cash from Investing Activities shows it stood at -$11381.2 in 2021, then plunged by 2743.0% to -$323567.3 in 2022, then rose by 18.06% to -$265140.1 in 2023, then soared by 46.65% to -$141461.0 in 2024, then soared by 45.21% to -$77501.4 in 2025.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$77501.4, -$63653.6, and -$57407.1 for Q3 2025, Q2 2025, and Q1 2025 respectively.